Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Reduced bone mineral density in HIV-positive individuals.

Literature DB >> 11546951

Reduced bone mineral density in HIV-positive individuals.

A L Moore¹, A Vashisht, C A Sabin, A Mocroft, S Madge, A N Phillips, J W Studd, M A Johnson.

Abstract

A total of 105 HIV-positive patients underwent dual-energy X-ray absorbtiometry (DEXA) scan to assess bone mineral density (BMD). The prevalence of reduced BMD was found to be 71% and was higher in patients who had ever been treated with protease inhibitors (PI). Our results suggest a possible association between PI and reduced BMD, and further complicate the debate regarding when to commence treatment of HIV and with what agents to start.

Entities: Disease Species

Mesh：

Substances：
Protease Inhibitors

Year: 2001 PMID： 11546951 DOI： 10.1097/00002030-200109070-00019

Source DB: PubMed Journal: AIDS ISSN： 0269-9370 Impact factor: 4.177

Keyword Cloud
Cited

35 in total

1. Bone disease in HIV infection.

Authors: Maristella Francesca Saccomanno; Adriana Ammassari
Journal: Clin Cases Miner Bone Metab Date: 2011-01

Review 2. Bleeding disorders and reduced bone density.

Authors: Hassan Mansouritorghabeh; Zahra Rezaieyazdi
Journal: Rheumatol Int Date: 2010-05-27 Impact factor: 2.631

3. Endocrinopathies in HIV, AIDS and HAART.

Authors: Amrit Bhangoo; Ninad Desai
Journal: Rev Endocr Metab Disord Date: 2013-06 Impact factor: 6.514

4. Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study.

Authors: Denise L Jacobson; Donna Spiegelman; Tamsin K Knox; Ira B Wilson
Journal: J Acquir Immune Defic Syndr Date: 2008-11-01 Impact factor: 3.731

Reduced bone mineral density in HIV-positive individuals.

1. Bone disease in HIV infection.

Review 2. Bleeding disorders and reduced bone density.

3. Endocrinopathies in HIV, AIDS and HAART.

4. Evolution and predictors of change in total bone mineral density over time in HIV-infected men and women in the nutrition for healthy living study.

Review 5. Bone and vitamin D metabolism in HIV.

6. Prevalence of abnormal bone mineral density in hiv-positive patients in ibadan, Nigeria.

7. Longitudinal analysis of bone density in human immunodeficiency virus-infected women.

Review 8. Gynecologic issues in the HIV-infected woman.

9. The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling.

10. Bone effects of rosiglitazone in HIV-infected patients with lipoatrophy.